Clinical Trial

Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 31, 2024 (before its estimated June 27, 2025 completion). Its status may not reflect the trial's current state.
Summary
Registry Objectives The overall objective of the registry is to collect quality and safety data to assess the long-term outcomes of Kerecis Omega3 SurgiBind in surgical procedures to reinforce soft tissue and prevent surgical complications. The ultimate goal of the registry is to enhance the quality of care, patient outcomes and establish a resource to facilitate the use of fish skin in preventing surgical wound dehiscence and surgical site infection.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-06-01; most recent amendment 2024-12-27.
Status change: Recruiting → Active, Not Recruiting 2024-12-27
Trial Details
NCT Number NCT05898711
Lead Sponsor Kerecis Ltd.
Conditions Surgery-Complications
Enrollment 200 participants
Start Date 2022-01-27
Primary Completion 2025-06-27 (estimated)
Study Completion 2026-01-27 (estimated)
Updated on ClinicalTrials.gov 2024-12-31